BioBreakthroughs

Join us on the latest episode! Our Guest: Frank Bedu-Addo , President and CEO at PDS Biotechnology Corporation. What you'll get out of this episode: PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid nanoparticle-based immunotherapy. Their lead candidate, PDS0101, demonstrated over 2x improvement in survival for HPV-positive head and neck cancer. The pl...

Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories. What you'll get out of this episode: Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions. The company’s patented technology improves absorption via buccal and GI routes. First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment...

Join us on the latest episode! Our Guest: Michael Oleksiw , CEO at Pleio. What you'll get out of this episode: Human + AI Synergy : Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence. Overcoming Emotional Barriers : Emotions like fear, loneliness, and stigma are major challenges after diagnosis. Real-World Impact : Pleio's approach improved adherence rat...

Join us on the latest episode! Our Guest: Bill Peters , CEO at On Target Laboratories . What you'll get out of this episode: Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging. Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes...

Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics. What you'll get out of this episode: Company Focus : Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending. Significant Milestones : This year, Arcutis launched two new products and partnered...

Join us on the latest episode! Our Guests: Aaron Mackey, SVP of AI/Data Science at Lokavant & Jonathan Crowther, Head of Predictive Analytics at Pfizer. What you'll get out of this episode: Causal AI Explained : Aaron Mackey from Lokavant and Jonathan Crowther from Pfizer discuss the capabilities of causal AI in differentiating cause and effect in clinical trials. Comparison to Generative AI :...

Join us on the latest episode! Our Guest: Joerg Ahlgrimm, CEO at SK Pharmteco. What you'll get out of this episode: Joerg Ahlgrimm discusses his journey in the pharmaceutical industry and his role at SK Pharmteco. The strategic integration of companies under SK Pharmteco to enhance global CDMO capabilities. The importance of a patient-centric approach in driving company success and innovation. Cha...

Join us on the latest episode! Our Guest: Elliott Green, Co-Founder & CEO at Dandelion Health. What you'll get out of this episode: Elliot Green's transition from Oscar Health to founding Dandelion Health. Dandelion Health's innovative approach to real-world data and clinical AI. The importance of longitudinal data in advancing precision medicine. The potential of AI to accelerate drug develop...

Join us on the latest episode! Our Guest: Nicole K. Paulk, CEO & Founder at Siren Biotechnology. What you'll get out of this episode: Nicole Paulk's early inspiration in gene therapy during her PhD at OHSU. The transition from academia to entrepreneurship amid COVID-19. Siren Biotechnology's innovative approach with AAV immunogene therapy. The challenges and successes in securing funding and n...

Join us on the latest episode! Our Guest: Sam Cooper, Co-Founder & CTO at Phenomic. What you'll get out of this episode: Sam Cooper shares his journey from Imperial College London to founding Phenomic. Phenomic's innovative approach combines AI with biological research. The company focuses on developing drugs targeting the tumor stroma. Phenomic's partnership with TileDB and Boehringer Ingelhe...

Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant. What you'll get out of this episode: Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility. Christine Senn highlights the importance of thorough feasibility processes in rare disease trials. The nee...

Join us on the latest episode! Our Guest: Dr. Sam Clark, Founder and CEO at Terran Biosciences. What you'll get out of this episode: Revolutionizing Treatments : Dr. Sam Clark discusses Terran Biosciences' mission to innovate treatments for neurological and psychiatric conditions. Innovative Drug Development : The company focuses on creating new mechanisms for treating depression, bipolar disorder...

Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals. What you'll get out of this episode: Dr. Michael Kyle's Background : Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals. Understanding Obesity : A discussion on different types of obesity and the importance of tail...

Join us on the latest episode! Our Guest: Colin Weller, VP & GM of Evidence Platform at Medable. What you'll get out of this episode: Introduction of Colin Weller: Vice President and GM of Evidence Platform at Medable, Colin Weller discusses his role in advancing clinical research technology to streamline drug approvals. Challenges in Drug Development: Weller details the stagnant pace of drug...

Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda. What you'll get out of this episode: Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO. Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy. The...

Join us on the latest episode! Our Guest: Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio. What you'll get out of this episode: Samantha Dale Strasser, co-founder and Chief Science Officer of Pepper Bio, shares her transition from academia to entrepreneurship, driven by a personal mission to change healthcare outcomes. Pepper Bio, located in Boston, leverages transomics to integrate mul...

Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals. What you'll get out of this episode: Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals. Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder. The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treat...

Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines. What you'll get out of this episode: Discussion on innovative CNS drug development on BioBreakthroughs podcast. Learn about Praxis' genetics-inspired approach to tackling complex brain diseases. Souza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE stu...

Join us on the latest episode! Our Guest: Steve Reed, Co-Founder & Chief Executive Officer Of HDT Bio What you'll get out of this episode: Reed shares his 40-year journey in microbiology and immunology. Discussion on HDT Bio's approach to vaccine development for infectious diseases and cancer. Insight into the Amplify vaccine platform and its impact on global health. Reed's perspective on vacc...

Join us on the latest episode! Our Guest: Gadi Saarony, CEO of Advarra What you'll get out of this episode: Discussing the challenges in clinical research and strategies for overcoming them. Exploring the role of technology in modern clinical trials. Advarra's innovative approach to streamlining clinical research processes. Insights on the future of clinical trials and healthcare innovation. Key t...

Join us on the latest episode! Our Guest: David Stein, CEO of Babson Diagnostics. What you'll get out of this episode: Insightful discussion on innovative blood testing technology. Stein's journey in the healthcare and medtech sectors. Challenges and triumphs in developing new blood testing methods. Future prospects and impact of Babson Diagnostics in healthcare. To learn more about our guests and...

Join us on the latest episode! Our Guests: Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University. What you'll get out of this episode: The vision and strategies behind the Launchpad Houston as a key location for medical innovation Impact on the local and national biotech scene Upcoming projects and future prospects in biotechnology To learn more about our guests and...

Join us on the latest episode! Our Guest: Katie Baca-Motes, Co-Founder And CSO At Scripps Research – Digital Trials And Engagement. What you'll get out of this episode: The shift towards decentralized clinical trials. The impact of wearable technology on health monitoring. The role of patient-mediated Electronic Health Records (EHRs). Exploration of AI, wearables, and patient-centric data strategi...

Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals What you'll get out of this episode: Discussing LUMRYZ, a new narcolepsy drug. Insights into the challenges of narcolepsy treatment. Avadel's future plans in healthcare innovation. To learn more about Greg and Avadel Pharmaceuticals: Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/ Website: https://w...

Join us on the latest episode! Our Guest: Shankar Musunuri, Chairman, CEO and Co-Founder Ocugen What you'll get out of this episode: Dr. Shankar Musunuri of Ocugen discusses gene and cell therapy innovations Focus on tackling unmet needs in ophthalmology and vaccine development Insights into Ocugen's unique platforms and global health impact Future prospects in biotech and healthcare advancements...